| Autor: |
M, Ackermann-Zare, V, Ancrenaz, N, Blazek, C, Brun, D, Gani, N, Grandjean, F, Marti-Klay, C, Trembleau, J, Wasem, N, Mach |
| Jazyk: |
francouzština |
| Rok vydání: |
2014 |
| Předmět: |
|
| Zdroj: |
Revue medicale suisse. 10(431) |
| ISSN: |
1660-9379 |
| Popis: |
A better understanding of the molecular deregulation leading to carcinogenesis allows the development of numerous novel targeted therapeutic candidates. Clinical research in oncology is a critical step to evaluate in a thorough manner the safety and efficacy of these innovative compounds. During the last four years the fruitful partnership between the Geneva University Hospitals and the Dr. Henri Dubois-Ferriere Dinu Lipatti Foundation lead to a dedicated clinical research unit for cancer patients with a staff of ten people. Since 2010, more than 300 patients were enrolled in more than 70 distinct clinical trials evaluating novel therapies for both solid tumors and hematologic malignancies. Interestingly, classical cytostatic drugs now represent only a small fraction of the new anti-cancer therapies in the pipeline. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
